NEU2 and neoplasm: In our study, Neu2 was found to promote EMT, specifically the partial EMT (pEMT) program, which confers hybrid epithelial-mesenchymal properties and is closely linked to increased tumor plasticity, invasiveness, and resistance to therapy 79, 80.